196 related articles for article (PubMed ID: 12972471)
1. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis.
Garnero P; Conrozier T; Christgau S; Mathieu P; Delmas PD; Vignon E
Ann Rheum Dis; 2003 Oct; 62(10):939-43. PubMed ID: 12972471
[TBL] [Abstract][Full Text] [Related]
2. Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis.
Garnero P; Charni N; Juillet F; Conrozier T; Vignon E
Ann Rheum Dis; 2006 Dec; 65(12):1639-44. PubMed ID: 16569684
[TBL] [Abstract][Full Text] [Related]
3. A new marker for osteoarthritis: cross-sectional and longitudinal approach.
Reijman M; Hazes JM; Bierma-Zeinstra SM; Koes BW; Christgau S; Christiansen C; Uitterlinden AG; Pols HA
Arthritis Rheum; 2004 Aug; 50(8):2471-8. PubMed ID: 15334460
[TBL] [Abstract][Full Text] [Related]
4. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
5. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
Garnero P; Piperno M; Gineyts E; Christgau S; Delmas PD; Vignon E
Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
[TBL] [Abstract][Full Text] [Related]
6. Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis.
Manicourt DH; Bevilacqua M; Righini V; Famaey JP; Devogelaer JP
Drugs R D; 2005; 6(5):261-71. PubMed ID: 16128596
[TBL] [Abstract][Full Text] [Related]
7. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
[TBL] [Abstract][Full Text] [Related]
8. Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort.
Garnero P; Mazières B; Guéguen A; Abbal M; Berdah L; Lequesne M; Nguyen M; Salles JP; Vignon E; Dougados M
J Rheumatol; 2005 Apr; 32(4):697-703. PubMed ID: 15801028
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study.
Garnero P; Peterfy C; Zaim S; Schoenharting M
Arthritis Rheum; 2005 Sep; 52(9):2822-9. PubMed ID: 16145678
[TBL] [Abstract][Full Text] [Related]
10. Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate.
Christgau S; Henrotin Y; Tankó LB; Rovati LC; Collette J; Bruyere O; Deroisy R; Reginster JY
Clin Exp Rheumatol; 2004; 22(1):36-42. PubMed ID: 15005002
[TBL] [Abstract][Full Text] [Related]
11. Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis.
Gineyts E; Mo JA; Ko A; Henriksen DB; Curtis SP; Gertz BJ; Garnero P; Delmas PD
Ann Rheum Dis; 2004 Jul; 63(7):857-61. PubMed ID: 15194584
[TBL] [Abstract][Full Text] [Related]
12. Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations.
Rousseau JC; Chevrel G; Schott AM; Garnero P
Bone; 2010 Apr; 46(4):897-900. PubMed ID: 20005316
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of serum type I collagen C-telopeptide in patients with rapidly destructive osteoarthritis of the hip.
Berger CE; Kröner A; Stiegler H; Leitha T; Engel A
Int Orthop; 2005 Feb; 29(1):1-5. PubMed ID: 15625614
[TBL] [Abstract][Full Text] [Related]
14. Relationship between radiological knee osteoarthritis and biochemical markers of cartilage and bone degradation (urine CTX-II and NTX-I): the Matsudai Knee Osteoarthritis Survey.
Tanishi N; Yamagiwa H; Hayami T; Mera H; Koga Y; Omori G; Endo N
J Bone Miner Metab; 2009; 27(5):605-12. PubMed ID: 19381754
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis.
Kawana K; Takahashi M; Hoshino H; Kushida K
Clin Chim Acta; 2002 Feb; 316(1-2):109-15. PubMed ID: 11750280
[TBL] [Abstract][Full Text] [Related]
16. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
[TBL] [Abstract][Full Text] [Related]
17. The cartilage degradation marker, urinary CTX-II, is associated with the risk of incident total joint replacement in postmenopausal women. A 18 year evaluation of the OFELY prospective cohort.
Garnero P; Sornay-Rendu E; Chapurlat R
Osteoarthritis Cartilage; 2020 Apr; 28(4):468-474. PubMed ID: 31982562
[TBL] [Abstract][Full Text] [Related]
18. Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study.
Bettica P; Cline G; Hart DJ; Meyer J; Spector TD
Arthritis Rheum; 2002 Dec; 46(12):3178-84. PubMed ID: 12483721
[TBL] [Abstract][Full Text] [Related]
19. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression.
Sharif M; Kirwan J; Charni N; Sandell LJ; Whittles C; Garnero P
Rheumatology (Oxford); 2007 Jun; 46(6):938-43. PubMed ID: 17387119
[TBL] [Abstract][Full Text] [Related]
20. Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study.
Meulenbelt I; Kloppenburg M; Kroon HM; Houwing-Duistermaat JJ; Garnero P; Hellio Le Graverand MP; Degroot J; Slagboom PE
Ann Rheum Dis; 2006 Mar; 65(3):360-5. PubMed ID: 16079167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
